Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition characterized by painful, recurrent abscesses and nodules in areas rich in apocrine sweat glands, such as the armpits, groin, and buttocks. The condition typically begins after puberty and can have a significant impact on quality of life due to pain, scarring, and discharge of pus. Diagnosis of HS is based on clinical examination, often requiring a careful assessment of symptoms and physical findings. Treatment options aim to control symptoms, reduce inflammation, and prevent flare-ups. This may include topical or oral antibiotics, corticosteroids, retinoids, or immunosuppressive medications. In severe cases, surgical interventions such as drainage of abscesses, laser therapy, or excision of affected tissue may be necessary. Managing HS often requires a multidisciplinary approach involving dermatologists, surgeons, and other healthcare providers. Lifestyle modifications, such as weight loss and smoking cessation, may also help improve symptoms. Additionally, support groups and counseling can be beneficial for individuals coping with the emotional and psychological impact of HS. While HS can be challenging to treat, ongoing research is providing insights into the underlying mechanisms of the disease and leading to the development of new therapeutic approaches. Early diagnosis and intervention are essential for minimizing complications and improving outcomes for individuals living with HS.

Committee Members
Speaker at Dermatology and Cosmetology 2027 - Sergei A Grando

Sergei A Grando

University of California Irvine, United States
Speaker at Dermatology and Cosmetology 2027 - Nalini Kaul

Nalini Kaul

Princeton Consumer Research, Canada
Speaker at Dermatology and Cosmetology 2027 - Georgios N Stamatas

Georgios N Stamatas

SGS, France
Speaker at Dermatology and Cosmetology 2027 - George Sulamanidze

George Sulamanidze

The Clinic of Plastic Surgery and Aesthetic Dermatology, Totalcharm, Georgia
Tags

Submit your abstract Today

WhatsApp